Leveraged Loans May Get More Scrutiny If Democrats Win House
(Bloomberg) -- If the Democrats win the House in the midterm elections, U.S. loan market participants worry that regulators may sharpen their focus on riskier deals, which will result in a decline in issuance. The health care sector may benefit from the ensuing gridlock because it would reduce the possibility of regulatory changes.
Regulatory Comeback
- Leveraged lending guidance, which fell by the wayside under the Trump administration, could see a comeback -- or at least not loosen further -- if Nov. 6 is a good day for the Democrats
- "If the Democrats do win the House and/or the Senate I would expect them to cause gridlock in Washington and generate more noise around enforcing some of the regulation that was enacted during the Obama administration, specifically the leveraged lending guidance": John Sherman, portfolio manager at DDJ Capital Management, which has $8.6 billion in AUM
- If regulations are reenacted "that would likely decrease some issuance for the market and could potentially slow down some of the M&A and PE-backed lending": Sherman
- The regulatory landscape was also on the agenda at last month's LSTA annual conference
- "While the regulatory environment is relatively benign now, the coming midterm elections or exogenous events may lead to dramatic change," the LSTA said in a write up of its Oct. 24 event
- However, BlackRock doesn't expect Democrat House win/Republicans retain Senate outcome to affect regulation
- Sees "low risk of rollbacks to the administration's tax cuts and regulatory policies in the short term": BlackRock said in Nov. 5 note
- The Federal Reserve last month warned Wall Street banks about doing increasingly risky loan deals
- Health care issuers could benefit from the election, particularly if there is a stalemate if Democrats gain more power
- "Gridlock is positive for health care because you wouldn't see change on either side and it would bring stability on the regulation front": Sherman
- The fate of the Affordable Care Act and its impact on companies in the industry hinges on the outcome of the election; health care is one of the biggest talking points of the lead up to voting
- Health care borrowers account for $72.2b, or 10% of issuance in the U.S. institutional loans market YTD, the sixth largest industry, according to data compiled by Bloomberg
- Moving past midterms means loan investors will have one less thing to worry about, said Michael Marzouk, portfolio manager at Pacific Asset Management, which has more than $5 billion of loans under management
- "Getting it behind us usually is a positive as it removes the uncertainty": Marzouk
- Of the four possible outcomes -- Republicans retaining both the House and Senate, the Democrats winning either the House or the Senate or Democrats winning both -- none is particularly worrisome for the leveraged loan market
- "Under each of those scenarios, we don't see much volatility": Sherman
- "Loans have been a relative safe haven due to their seniority in the capital structure and floating rate coupons"
- Rates may be headed higher as the benchmark nears a seven-year high
--With assistance from Jeannine Amodeo.
To contact the reporter on this story: Kelsey Butler in New York at kbutler55@bloomberg.net
To contact the editors responsible for this story: James Crombie at jcrombie8@bloomberg.net, Faris Khan, Christopher Maloney
©2018 Bloomberg L.P.
- "Under each of those scenarios, we don't see much volatility": Sherman
Read more: Republicans Keeping House, Senate Is Risky for Bonds, Says BlackRock
Health Care Gridlock
Read more: Junk Bonds Poised for Post-Midterm Election Boost, Says Wells Fargo
Removing Uncertainty
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.